FOSUN PHARMA (02196) Stock Price, News, Quotes-Moomoo

HK Stock MarketDetailed Quotes

02196 FOSUN PHARMA

Watchlist

14.420
0.0000.00%

Pre-Opening Auction Dec 4 09:00 CST

38.43BMarket Cap16.29P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

No Data

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod
MT NewswiresDec 3 06:08 ET
Fosun Pharma (02196) has had 20 million shares released from pledge by its controlling shareholder, Fosun High Technology.
Fosun Pharma (02196) announced that on December 3, 2024, the company received a notification from its controlling shareholder Fosun...
Zhitong FinanceDec 3 05:18 ET
Fosun Pharma (02196.HK) subsidiary obtained pharmaceutical registration approval.
On December 3, Gelonghui reported that fosun pharma (02196.HK) announced that shanghai fosun pharma (Group) Co., Ltd. (hereinafter referred to as "the company") and shanghai henlius biotechnology Co., Ltd. and its holding subsidiaries (hereinafter collectively referred to as "henlius") have developed the Hanshuang (i.e., Shruvalumab injection, hereinafter referred to as "the pharmaceutical") combined with pemetrexed and carboplatin for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) gene mutation negative and anaplastic lymphoma kinase (ALK) negative that cannot be surgically removed.
Gelonghui FinanceDec 3 04:55 ET
fosun pharma (600196.SH): Taohong Siwu Granule has received the acceptance of pharmaceutical registration application.
Gelonghui December 3 | fosun pharma (600196.SH) announced that its holding subsidiary Hebei Wanbang Fulin Pharmaceutical Co., Ltd. recently had the pharmaceutical registration application for Taohong Siwu Granules accepted by the National Medical Products Administration. This new drug is a Class 3 traditional chinese medicine, mainly used for nourishing blood, promoting blood circulation, and removing blood stasis, intended for the syndrome of blood deficiency and blood stasis, with symptoms such as irregular menstruation, blood clots, sticky purple complexion, abdominal pain, and bloating. The prescription of this new drug is based on the Taohong Siwu Decoction from the Qing Dynasty's Chai Dehua's "Gynecology Ice Mirror", and has been included in the first batch of the "Catalog of Ancient Classic Prescriptions" by the State Administration of traditional chinese medicine.
Gelonghui FinanceDec 3 03:58 ET
Market bullish stimulus boosts Hong Kong pharmaceutical stocks, with Genshuo Niaoyao rising over 14%.
① What bullish impacts does the medical insurance centralized procurement have on pharmaceutical companies? ② How do institutions view the subsequent development of pharmaceutical stocks?
cls.cnDec 2 21:48 ET
China Securities Co.,Ltd.: In the 2024 version of the medical insurance catalog, the number of innovative drugs added has reached a new high, balancing 'ensuring basic coverage' and 'supporting genuine innovation'.
Overall situation of the 2024 medical insurance catalog: the results are stable, meeting expectations, with a record high in the number of new innovative drugs, reflecting a balanced consideration of fund safety, public medical needs, and support for innovation.
Zhitong FinanceDec 2 00:42 ET

Comments

Spinee

Jun 24 21:45

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

Spinee

Apr 25, 2023 11:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

Senorita Earnings

Mar 1, 2023 23:54

Columns Expert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...

Spinee

Dec 14, 2022 00:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $FOSUN PHARMA (02196.HK)$ shares were opened 12% higher to 29 yuan.
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$

Spinee

Dec 6, 2022 21:36

In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:

First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates;
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...

Heat List

Overall

No Data

Investment Theme

Aesthetic Medicine

Intraday0.00%